HF
DCOY

HRT Financial’s Decoy Therapeutics DCOY Stock Holding History

HRT Financial’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-176
Closed -$28K – 3589
2025
Q2 		$28K Buy
+176
New +$24.8K ﹤0.01% 2365
2022
Q1 		– Hold
0
– -$8K – 3794
2021
Q4 		– Hold
0
– – – 3034

Other funds holding DCOY

ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

HRT Financial's DCOY Position: Q3 2025 in Review

HRT Financial sold out of Decoy Therapeutics (DCOY) in Q3 2025, closing a stake of 176 shares — an estimated $28K sold.

HRT Financial first reported a position in DCOY in Q2 2025 and held it in 1 quarter. The position peaked at $28K in Q2 2025. 3 funds tracked by Wall St. Rank hold DCOY as of Q3 2025.

  • HRT Financial reported no remaining Decoy Therapeutics position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 176 Decoy Therapeutics shares in Q3 2025, an estimated $28K.
  • HRT Financial first reported a position in Decoy Therapeutics in Q2 2025 and held it in 1 quarter.
  • HRT Financial's Decoy Therapeutics position peaked at $28K in Q2 2025.
  • 3 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.